Developing & Manufacturing Drugs with HPAPIs
Summary: This article discusses how to effectively classify highly potent APIs (HPAPIs), and to help develop containment protocols and manufacturing processes that are both safe and efficient.
Meeting the Needs of Early-Phase Drug Sponsors with HPAPIs in the Pipeline
Summary: This webinar aims to address the specific needs of sponsors by providing valuable insights and practical strategies. Experts will explore…
Potent Product Manufacturing in a Multi-Product Facility
Gain insight into how to properly assess and categorize HPAPIs to develop an appropriate containment strategy to manufacture them safely.
Leveraging Oral Solid Dose Technologies for the Development and Manufacturing of Potent Treatments
Industry experts as they delve into the driving forces that have created the recent surge in treatments for oncology and rare disease.
Modern Modelling Tools for Small Molecule Solid Dose Manufacturing
During the webinar, viewers will gain valuable insights through a series of case studies demonstrating how mathematical and computerized models were utilized to improve scale-up and efficiency in oral solid dose manufacturing.
Utilizing Phase-Appropriate CMC Strategies Throughout Clinical Development
Learn how to accelerate and de-risk clinical-stage drug programs by understanding phase-appropriate strategies that can give your molecule the best chance for success!